• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

NIHR Oxford Health Biomedical Research Centre

Improving brain health: the future in mind

MENUMENU
  • About
    • About
    • Contact
    • Core facilities
    • Management and partners
    • Work with us
  • Clinical Research Facility
    • About the Clinical Research Facility
    • What can the Clinical Research Facility offer?
    • Examples of Clinical Research Facility activity
    • CRF publications
    • Get involved
    • Our staff
  • Research Themes
    • Overview of Research Themes
    • Adult Mental Health
    • Older Adults and Dementia
    • Precision Psychological Therapies
    • Clinical Research Infrastructure and Experimental Medicine
    • Informatics and Digital Health
    • Neuroimaging and Cognitive Neuroscience
    • Patient and Public Involvement
    • Training
    • Theme Leads
  • Our Work
    • Brain Health Centre
    • Oxford Precision Psychiatry Lab (OxPPL)
    • Oxford Dementia and Ageing Research (OxDARE)
    • Treatment Resistant Depression Clinic
  • News
  • Training & Events
    • Psychiatry department seminars
  • Patients & Public
    • About Patient and Public Involvement
    • Shape our research
    • Take part in our research
    • Resources for researchers
    • Resources for the public
    • Patient and Public Involvement Strategy
    • Young people’s involvement
  • Blog
You are here: Home / Research Themes / Theme Leads / Profile: Paul Harrison

Profile: Paul Harrison

Professor of Psychiatry, University of Oxford

Theme lead: Adult mental health disorders

Email: paul.harrison@psych.ox.ac.uk
Phone: 01865 618 329

My research addresses several aspects of translational neuroscience relevant to bipolar disorder and related conditions. I am Head of the Translational Neurobiology Group at the University of Oxford’s Department of Psychiatry.

An important starting point for the work is that many genes which affect risk of developing these disorders have been identified, but much less is known about how, why, and when, these factors increase risk. Underlying my research is the assumption that they operate to affect brain development, plasticity, and function, and our work is designed to investigate and clarify this. I have a particular interest in the risk genes which represent potential treatment targets. Genes of interest at present include CACNA1C, catechol-O-methyl transferase (COMT) and GRM3 (mGlu3).

As well as neurobiological research into genetic mechanisms, I am involved in several more clinically focused projects related to bipolar disorder, including functional neuroimaging (using fMRI and MEG), experimental medicine, and randomised clinical trials. For example, we are studying the acute effects of a COMT inhibitor on emotional processing and the brain’s response to stress, and the effects of a calcium channel antagonist drug on cognition, sleep, and brain activity in people with mood instability.

I trained in medicine and psychiatry in Oxford and London, and was a Wellcome Trust Senior Research Fellow before being appointed to my present post in 1997. I was awarded a Chair in 2000. I have published about 280 papers (Scopus h-index 63), and several books, including The Neuropathology of Schizophrenia, The Shorter Oxford Textbook of Psychiatry, Lecture Notes: Psychiatry, and Schizophrenia with Daniel Weinberger.

Clinical work:
My clinical work centres on bipolar disorder and treatment-resistant mood disorder.

Awards:
The CINP/Paul Janssen Schizophrenia Prize (1998), the British Association for Psychopharmacology Senior Clinical Prize (1999), the A.E. Bennett Award of the Society of Biological Psychiatry (2004), the Joel Elkes Research Award of the American College of Neuropsychopharmacology (2005), the CINP Lilly Clinical Neuroscience award (2010), and the ECNP Clinical Neuropsychopharmacology award (2012).

Positions:
I am currently Past President of the British Association for Psychopharmacology (2014-2016). I hold an Adjunct Faculty position at the Lieber Institute of Brain Development in Baltimore. I am Group Leader on the new Oxford Wellcome Centre for Integrative Neuroimaging, and Co-Director, Oxford Wellcome mental health doctoral training scheme. I am a Deputy Editor for Biological Psychiatry.

Primary Sidebar

  • Theme Leads Overview
  • Profile: Paul Harrison
  • Profile: Clare Mackay
  • Profile: Anke Ehlers
  • Profile: Catherine Harmer
  • Profile: Andrea Cipriani
  • Profile: Kia Nobre
  • Profile: Ilina Singh
  • Profile: Elizabeth Tunbridge

Footer

Follow us

  • Twitter
  • YouTube

Improving brain health: the future in mind

The National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) is a partnership between Oxford Health NHS Foundation Trust and the University of Oxford. We are part of the Oxford Academic Health Science Centre.

Oxford Academic Health Science Centre
  • Sitemap
  • Accessibility
  • Disclaimer
  • Cookies
  • Contact

© 2021 NIHR Oxford Health Biomedical Research Centre · Log in

Cookies

This site uses cookies: See our privacy policy